Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European Notebook: Trademarks, Trade Secrets And Task Forces

Executive Summary

New European legislation and rules on trademarks and trade secrets, the transatlantic transfer of data, and anticounterfeiting measures advanced during February, while streamlining generics approvals were featured during the EU-US TTIP negotiations; the UK referendum on whether to exit the EU set for mid-June.

You may also be interested in...



French Industry Head Lauds New Drug Pricing Deal

Agreement includes reference price floor for products of higher therapeutic value; trade group says deal reflects "new pragmatism by regulators, with more predictability of pricing and more use of real-world data.

European Notebook: Clinical Trial Fatality; Affordable Medicines Debate; Physician Payment Disclosure

One death and five healthy volunteers hospitalized in a Phase I study in France; EU Council looks set to debate patient access to medicines; and the two Mercks set to continue litigation in Europe and the US over use of the Merck word, straining their 60-year-old agreement. Generics/biosimilar trade group adopts physician payment disclosure policy.

The Brexit Effect: What Would It Mean For Europe's Future Patent System?

UK referendum on whether to remain in EU will take place around the time that the Unified Patent Court is expected to launch.

Topics

Related Companies

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel